Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
Businesswire·2026-06-26 04:15

公司融资动态 - Definium Therapeutics, Inc. (Nasdaq: DFTX) 完成了其先前宣布的承销公开发行，共发行了23,676,471股无面值普通股 [1] - 此次发行包含了承销商全额行使了其超额配售选择权，额外购买了3,088,235股 [1] 公司业务定位 - 公司是一家处于临床开发后期的生物制药公司，致力于开发新一代疗法，旨在解决精神和神经系统疾病的根本原因 [1]

Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares - Reportify